Revenio Group Oyj engages in ophthalmic diagnostics and the manufacture and sale of ophthalmic devices. The company is headquartered in Vantaa, Etela-Suomen and currently employs 248 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
Revenio Group Oyj hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü yıllık ödenmektedir ve son temettü hariç tarihi Apr 11, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.45
Apr 11, 2025
Ödeme Sıklığı
Ödeme Oranı
Yıllık
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Apr 11, 2025
$0.40
Apr 14, 2025
Apr 23, 2025
Apr 5, 2024
$0.38
Apr 8, 2024
Apr 15, 2024
Mar 24, 2023
$0.36
Mar 27, 2023
Apr 3, 2023
Apr 11, 2022
$0.34
Apr 12, 2022
Apr 21, 2022
Mar 18, 2021
$0.32
Mar 19, 2021
Mar 26, 2021
Jun 9, 2020
$0.30
Jun 10, 2020
Jun 17, 2020
Dividend Grafikleri
REVXF Kâr Payları
REVXF Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Revenio Group Oyj'in şu anki temettü ödemesi ve yıllık temettüsü nedir?